Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
Exploring Skin Wound Healing Models and the Impact of Natural Lipids on the Healing Process
2024 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
Works of Steve Abella being referenced
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
2015
Epidermal Abnormalities May Distinguish Type 2 from Type 1 and Type 3 of Gaucher Disease
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Steve Abella | 131 | 108 | 113 | 21 | 382 | |
| Sophie Kaltenbach | 74 | 231 | 72 | 21 | 407 | |
| Anna Colpo | 77 | 129 | 46 | 24 | 366 | |
| P Verroust | 40 | 216 | 52 | 26 | 457 | |
| Brian L. Abbott | 85 | 145 | 52 | 24 | 397 | |
| H Urbańska-Ryś | 192 | 110 | 149 | 24 | 437 | |
| Pierluigi Marradi | 96 | 72 | 68 | 22 | 369 | |
| U. Hettmannsperger | 36 | 106 | 44 | 15 | 421 | |
| Parvaneh Vossough | 142 | 159 | 29 | 28 | 418 | |
| Hidenori Kasahara | 59 | 195 | 51 | 21 | 449 | |
| Iwona Janicka | 63 | 114 | 32 | 18 | 353 |
All Works
Loading papers...